Mesoblast Limited
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| FY2018 | 229.34x | $0.04 | $8.24 |
| FY2019 | 439.53x | $0.03 | $14.74 |
| FY2020 | 308.36x | $0.06 | $16.98 |
| FY2021 | 837.70x | $0.01 | $9.60 |
| FY2022 | 370.74x | $0.02 | $5.82 |
| FY2023 | 238.80x | $0.01 | $2.20 |
| FY2024 | 3,830.45x | $0.01 | $19.80 |
| FY2025 | 1,382.82x | $0.01 | $18.58 |